FASEB J. Uncover Your Biological Pathway
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-098038.
(The FASEB Journal. 2008;22:2747-2757.)
© 2008 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.07-098038v1
22/8/2747    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spadaro, M.
Right arrow Articles by Giovarelli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spadaro, M.
Right arrow Articles by Giovarelli, M.

Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells

Michela Spadaro*,1, Cristiana Caorsi{dagger},1, Patrizia Ceruti{dagger}, Atul Varadhachary{ddagger}, Guido Forni*, Federica Pericle{ddagger} and Mirella Giovarelli{dagger},2

* Molecular Biotechnology Center, Department of Clinical and Biological Science, and

{dagger} Center for Experimental Research and Medical Studies, Department of Medicine and Experimental Oncology, University of Turin, Turin, Italy; and

{ddagger} Agennix, Inc., Houston, Texas

2 Correspondence: Department of Medicine and Experimental Oncology, University of Turin, Corso Raffaello 30, 10126 Torino, Italy. E-mail: mirella.giovarelli{at}unito.it

Lactoferrin (LF) is an important protein component of the innate immune system that is broadly distributed within the body fluids. LF is endowed with multiple biological activities. Talactoferrin (TLF), a recombinant human LF, is in clinical development as an anticancer agent and is entering Phase III clinical trials. Here, we show that TLF induces the maturation of human dendritic cells (DCs) derived from monocytes. TLF, at physiologically relevant concentrations (100 µg/ml) up-regulates the expression of human leukocyte antigen (HLA) class II, CD83, CD80, and CD86 costimulatory molecule and CXCR4 and CCR7 chemokine receptors, acting primarily through the p38 MAPK signaling pathway. DCs matured by TLF displayed an enhanced release of IL-8 and CXCL10, as well as a significantly reduced production of IL-6, IL-10, and CCL20. They also display a reduced ability to take up antigen and increased capacity to trigger proliferation and release IFN-{gamma} in the presence of allogeneic human T cells. TLF-matured DCs are able to prime naive T cells to respond to KLH antigen and display a significantly increased capacity to present Flu-MA58–66 peptide to HLA-A2-matched T cells. These data suggest that a key immunomodulatory function that may be mediated by TLF is to link the innate with adaptive immunity through DC maturation.—Spadaro, M., Caorsi, C., Ceruti, P., Varadhachary, A., Forni, G., Pericle, F., Giovarelli, M. Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells.


Key Words: adaptive immunity • antigen presentation • T-cell activation




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
W. C. Adams, E. Bond, M. J. E. Havenga, L. Holterman, J. Goudsmit, G. B. Karlsson Hedestam, R. A. Koup, and K. Lore
Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN
J. Gen. Virol., July 1, 2009; 90(7): 1600 - 1610.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.